Endocrine Abstracts

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age women and has effects from adolescence to menopause with a prevalence between 10% to 13% (1). In this talk with reference to evidence based international guidelines (1) and clinical expertise I will discuss rationale, methods and evidence of pre-conception health optimisation for women with PCOS and potential obstetric outcomes, including challenges around obesity management.  I will also discuss a fertility investigation pathway and management algorithm, including clinical scenarios to illustrate the recent updated International PCOS guidelines. 

Ref (1) 2023 International Evidence-based Guideline for Assessment and Management of Polycystic ovary Syndrome, Journal of Clinical Endocrinology and Metabolism 2023